Lakefront Biotherapeutics (LKFT) Share-based Compensation Growth (1y) (2017 - 2022)
Lakefront Biotherapeutics (LKFT) Share-based Compensation Growth (1y) (2017 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 118.32% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -40.86% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.18% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5,886.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.64 Bn | 1.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -22.01% |
| Jun 30, 2021 | -14.15% |
| Mar 31, 2021 | 100.05% |
| Jun 30, 2020 | 182.89% |
| Mar 31, 2020 | 53.78% |
| Dec 31, 2019 | 16.14% |
| Sep 30, 2019 | 20.23% |
| Jun 30, 2019 | 28.50% |
| Mar 31, 2019 | 19.98% |
| Dec 31, 2018 | 128.38% |
| Sep 30, 2018 | 100.11% |
| Jun 30, 2018 | -99.91% |
| Mar 31, 2018 | 30.43% |
| Jun 30, 2017 | 297,548.59% |
| Mar 31, 2017 | 58.94% |